Need help finding what you are looking for?
Contact Us
PUBLISHER: Inkwood Research | PRODUCT CODE: 1130701
PUBLISHER: Inkwood Research | PRODUCT CODE: 1130701
Europe Contrast Enhanced Ultrasound Market Forecast 2022-2030
PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
KEY FINDINGS
The Europe contrast enhanced ultrasound market growth is expected to progress at a CAGR of 5.28% during the forecast period, 2022-2030. The recent approval of contrast agents for pediatrics is set to boost growth opportunities. For instance, SonoVue was the first contrast agent in July 2017 to get approval for vesicoureteral reflux in European pediatric patients.
MARKET INSIGHTS
Spain, Italy, Germany, France, Nordic Countries, the United Kingdom, and Rest of Europe are analyzed for the Europe contrast enhanced ultrasound market growth evaluation. Ultrasound is one of the most used imaging techniques in Germany. Contrast enhanced ultrasound is extensively used in the German imaging technology sector. This is accredited to the simplicity of use, the convenience of access, and the breadth of diagnostic applications. Accordingly, the demand for ultrasound services in prenatal care is projected to increase. Thus, the growing birth rates, alongside government efforts, are expected to offer growth opportunities.
In the Nordic region, the residents are covered by publicly financed comprehensive healthcare systems. These facilitate high quality healthcare at minimal or no direct patient cost. Also, it invests significantly in healthcare. In addition, the region is inclined toward adopting advanced technologies. As a result, robust healthcare policies, rising lifestyle disease concerns, and accommodating market prospects, offer growth opportunities for contrast enhanced ultrasound in the Nordic region.
Furthermore, in the Rest of Europe segment, the growing prevalence of non-communicable diseases, the rising geriatric population, and the increasing healthcare spending propel market growth. This is because contrast enhanced ultrasound is evaluated as a cheaper alternative to traditional ultrasound techniques.
COMPETITIVE INSIGHTS
Some of the leading companies in the market include: Shenzhen Mindray Bio-Medical Electronics Co Ltd, Siemens Healthineers AG, Bayer AG, Daiichi Sankyo Company, etc.
Our report offerings include:
- Explore key findings of the overall market
- Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
- Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
- Market Segmentation caters to a thorough assessment of key segments with their market estimations
- Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
- Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
- The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
- Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Product Code: 48380
TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
- 1.1. STUDY OBJECTIVES
- 1.2. SCOPE OF STUDY
- 1.3. METHODOLOGY
- 1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
- 2.1. MARKET SIZE & ESTIMATES
- 2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
- 3.1. KEY DRIVERS
- 3.1.1. SURGING PREVALENCE OF CHRONIC DISEASES
- 3.1.2. HEALTH PRACTITIONERS PREFER CONTRAST ENHANCED ULTRASOUND IMAGING
- 3.1.3. TECHNOLOGICAL ADVANCEMENTS IN DIAGNOSIS
- 3.2. KEY RESTRAINTS
- 3.2.1. NON-UNIFORMITY OF CONTRAST AGENTS
- 3.2.2. DIFFICULTY IN ADOPTION IN THE CURRENT HEALTHCARE SYSTEM
4. KEY ANALYTICS
- 4.1. IMPACT OF COVID-19 ON CONTRAST ENHANCED ULTRASOUND MARKET
- 4.2. KEY MARKET TRENDS
- 4.3. PORTER'S FIVE FORCES ANALYSIS
- 4.3.1. BUYERS POWER
- 4.3.2. SUPPLIERS POWER
- 4.3.3. SUBSTITUTION
- 4.3.4. NEW ENTRANTS
- 4.3.5. INDUSTRY RIVALRY
- 4.4. OPPORTUNITY MATRIX
- 4.5. VENDOR LANDSCAPE
- 4.6. VALUE CHAIN ANALYSIS
- 4.7. KEY BUYING CRITERIA
- 4.7.1. COST EFFICIENCY
- 4.7.2. PRODUCT FEATURES
- 4.7.3. END-USE
- 4.8. REGULATORY FRAMEWORK
5. MARKET BY PRODUCT
- 5.1. EQUIPMENT
- 5.2. CONTRAST AGENT
6. MARKET BY TYPE
- 6.1. NON-TARGETED
- 6.2. TARGETED
7. MARKET BY END-USER
- 7.1. HOSPITALS
- 7.2. CLINICS
- 7.3. AMBULATORY DIAGNOSTIC CENTERS
8. GEOGRAPHICAL ANALYSIS
- 8.1. EUROPE
- 8.1.1. MARKET SIZE & ESTIMATES
- 8.1.2. KEY GROWTH ENABLERS
- 8.1.3. KEY CHALLENGES
- 8.1.4. KEY PLAYERS
- 8.1.5. COUNTRY ANALYSIS
- 8.1.5.1. UNITED KINGDOM
- 8.1.5.2. GERMANY
- 8.1.5.3. FRANCE
- 8.1.5.4. ITALY
- 8.1.5.5. SPAIN
- 8.1.5.6. NORDIC COUNTRIES
- 8.1.5.7. REST OF EUROPE
9. COMPETITIVE LANDSCAPE
- 9.1. KEY STRATEGIC DEVELOPMENTS
- 9.1.1. MERGERS & ACQUISITIONS
- 9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
- 9.1.3. PARTNERSHIPS & AGREEMENTS
- 9.1.4. BUSINESS EXPANSIONS & DIVESTITURES
- 9.2. COMPANY PROFILES
- 9.2.1. BAYER AG
- 9.2.2. BRACCO DIAGNOSTIC INC
- 9.2.3. DAIICHI SANKYO COMPANY LIMITED
- 9.2.4. GE HEALTHCARE
- 9.2.5. KONINKLIJKE PHILIPS NV
- 9.2.6. LANTHEUS MEDICAL IMAGING INC
- 9.2.7. NANOPET PHARMA GMBH
- 9.2.8. SANOCHEMIA PHARMAZEUTIKA GMBH
- 9.2.9. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO LTD
- 9.2.10. SIEMENS HEALTHINEERS AG
- 9.2.11. TAEJOON PHARM
- 9.2.12. TRIVITRON HEALTHCARE
Product Code: 48380
TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
- 1.1. STUDY OBJECTIVES
- 1.2. SCOPE OF STUDY
- 1.3. METHODOLOGY
- 1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
- 2.1. MARKET SIZE & ESTIMATES
- 2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
- 3.1. KEY DRIVERS
- 3.1.1. SURGING PREVALENCE OF CHRONIC DISEASES
- 3.1.2. HEALTH PRACTITIONERS PREFER CONTRAST ENHANCED ULTRASOUND IMAGING
- 3.1.3. TECHNOLOGICAL ADVANCEMENTS IN DIAGNOSIS
- 3.2. KEY RESTRAINTS
- 3.2.1. NON-UNIFORMITY OF CONTRAST AGENTS
- 3.2.2. DIFFICULTY IN ADOPTION IN THE CURRENT HEALTHCARE SYSTEM
4. KEY ANALYTICS
- 4.1. IMPACT OF COVID-19 ON CONTRAST ENHANCED ULTRASOUND MARKET
- 4.2. KEY MARKET TRENDS
- 4.3. PORTER'S FIVE FORCES ANALYSIS
- 4.3.1. BUYERS POWER
- 4.3.2. SUPPLIERS POWER
- 4.3.3. SUBSTITUTION
- 4.3.4. NEW ENTRANTS
- 4.3.5. INDUSTRY RIVALRY
- 4.4. OPPORTUNITY MATRIX
- 4.5. VENDOR LANDSCAPE
- 4.6. VALUE CHAIN ANALYSIS
- 4.7. KEY BUYING CRITERIA
- 4.7.1. COST EFFICIENCY
- 4.7.2. PRODUCT FEATURES
- 4.7.3. END-USE
- 4.8. REGULATORY FRAMEWORK
5. MARKET BY PRODUCT
- 5.1. EQUIPMENT
- 5.2. CONTRAST AGENT
6. MARKET BY TYPE
- 6.1. NON-TARGETED
- 6.2. TARGETED
7. MARKET BY END-USER
- 7.1. HOSPITALS
- 7.2. CLINICS
- 7.3. AMBULATORY DIAGNOSTIC CENTERS
8. GEOGRAPHICAL ANALYSIS
- 8.1. EUROPE
- 8.1.1. MARKET SIZE & ESTIMATES
- 8.1.2. KEY GROWTH ENABLERS
- 8.1.3. KEY CHALLENGES
- 8.1.4. KEY PLAYERS
- 8.1.5. COUNTRY ANALYSIS
- 8.1.5.1. UNITED KINGDOM
- 8.1.5.2. GERMANY
- 8.1.5.3. FRANCE
- 8.1.5.4. ITALY
- 8.1.5.5. SPAIN
- 8.1.5.6. NORDIC COUNTRIES
- 8.1.5.7. REST OF EUROPE
9. COMPETITIVE LANDSCAPE
- 9.1. KEY STRATEGIC DEVELOPMENTS
- 9.1.1. MERGERS & ACQUISITIONS
- 9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
- 9.1.3. PARTNERSHIPS & AGREEMENTS
- 9.1.4. BUSINESS EXPANSIONS & DIVESTITURES
- 9.2. COMPANY PROFILES
- 9.2.1. BAYER AG
- 9.2.2. BRACCO DIAGNOSTIC INC
- 9.2.3. DAIICHI SANKYO COMPANY LIMITED
- 9.2.4. GE HEALTHCARE
- 9.2.5. KONINKLIJKE PHILIPS NV
- 9.2.6. LANTHEUS MEDICAL IMAGING INC
- 9.2.7. NANOPET PHARMA GMBH
- 9.2.8. SANOCHEMIA PHARMAZEUTIKA GMBH
- 9.2.9. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO LTD
- 9.2.10. SIEMENS HEALTHINEERS AG
- 9.2.11. TAEJOON PHARM
- 9.2.12. TRIVITRON HEALTHCARE
LIST OF TABLES
- TABLE 1: EUROPE MARKET SNAPSHOT - CONTRAST ENHANCED ULTRASOUND
- TABLE 2: EXAMPLES OF CURRENT CLINICAL ULTRASOUND CONTRAST AGENTS
- TABLE 3: EXAMPLES OF EMERGING ULTRASOUND MICROBUBBLES-BASED TECHNIQUES
- TABLE 4: REGULATORY FRAMEWORK
- TABLE 5: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
- TABLE 6: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, BY PRODUCT, FORECAST YEARS, 2022-2030 (IN $ MILLION)
- TABLE 7: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
- TABLE 8: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
- TABLE 9: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, BY END-USER, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
- TABLE 10: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, BY END-USER, FORECAST YEARS, 2022-2030 (IN $ MILLION)
- TABLE 11: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
- TABLE 12: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
- TABLE 13: LEADING PLAYERS OPERATING IN EUROPE CONTRAST ENHANCED ULTRASOUND MARKET
- TABLE 14: LIST OF MERGERS & ACQUISITIONS
- TABLE 15: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
- TABLE 16: LIST OF PARTNERSHIPS & AGREEMENTS
- TABLE 17: LIST OF BUSINESS EXPANSIONS & DIVESTITURES
LIST OF FIGURES
- FIGURE 1: KEY MARKET TRENDS
- FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
- FIGURE 3: OPPORTUNITY MATRIX
- FIGURE 4: VENDOR LANDSCAPE
- FIGURE 5: VALUE CHAIN ANALYSIS
- FIGURE 6: KEY BUYING CRITERIA
- FIGURE 7: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2021
- FIGURE 8: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, BY EQUIPMENT, 2022-2030 (IN $ MILLION)
- FIGURE 9: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, BY CONTRAST AGENT, 2022-2030 (IN $ MILLION)
- FIGURE 10: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, GROWTH POTENTIAL, BY TYPE, IN 2021
- FIGURE 11: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, BY NON-TARGETED, 2022-2030 (IN $ MILLION)
- FIGURE 12: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, BY TARGETED, 2022-2030 (IN $ MILLION)
- FIGURE 13: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, GROWTH POTENTIAL, BY END-USER, IN 2021
- FIGURE 14: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, BY HOSPITALS, 2022-2030 (IN $ MILLION)
- FIGURE 15: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, BY CLINICS, 2022-2030 (IN $ MILLION)
- FIGURE 16: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, BY AMBULATORY DIAGNOSTIC CENTERS, 2022-2030 (IN $ MILLION)
- FIGURE 17: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
- FIGURE 18: UNITED KINGDOM CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
- FIGURE 19: GERMANY CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
- FIGURE 20: FRANCE CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
- FIGURE 21: ITALY CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
- FIGURE 22: SPAIN CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
- FIGURE 23: NORDIC COUNTRIES CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
- FIGURE 24: REST OF EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
LIST OF FIGURES
- FIGURE 1: KEY MARKET TRENDS
- FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
- FIGURE 3: OPPORTUNITY MATRIX
- FIGURE 4: VENDOR LANDSCAPE
- FIGURE 5: VALUE CHAIN ANALYSIS
- FIGURE 6: KEY BUYING CRITERIA
- FIGURE 7: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2021
- FIGURE 8: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, BY EQUIPMENT, 2022-2030 (IN $ MILLION)
- FIGURE 9: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, BY CONTRAST AGENT, 2022-2030 (IN $ MILLION)
- FIGURE 10: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, GROWTH POTENTIAL, BY TYPE, IN 2021
- FIGURE 11: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, BY NON-TARGETED, 2022-2030 (IN $ MILLION)
- FIGURE 12: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, BY TARGETED, 2022-2030 (IN $ MILLION)
- FIGURE 13: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, GROWTH POTENTIAL, BY END-USER, IN 2021
- FIGURE 14: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, BY HOSPITALS, 2022-2030 (IN $ MILLION)
- FIGURE 15: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, BY CLINICS, 2022-2030 (IN $ MILLION)
- FIGURE 16: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, BY AMBULATORY DIAGNOSTIC CENTERS, 2022-2030 (IN $ MILLION)
- FIGURE 17: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
- FIGURE 18: UNITED KINGDOM CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
- FIGURE 19: GERMANY CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
- FIGURE 20: FRANCE CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
- FIGURE 21: ITALY CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
- FIGURE 22: SPAIN CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
- FIGURE 23: NORDIC COUNTRIES CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
- FIGURE 24: REST OF EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.